Interim pharmacokinetic (PK) and pharmacodynamic (PD) data from the first-in-human study of NUC-3373, a pyrimidine nucleotide analogue, in patients with advanced solid tumors

Essam Ghazaly, Sarah P. Blagden, Victoria K. Woodcock et al.|Annals of Oncology|2017

Cited by 4